A new therapy shows promise for patients with mild idiopathic pulmonary fibrosis. According to researchers in Japan, inhaled N-acetylcysteine (NAC) monotherapy preserves more lung function in some idiopathic pulmonary fibrosis (IPF) patients than no therapy.

Alzheimer's Society comment on research suggesting caffeine could protect against memory impairment and lower brain levels of protein (amyloid β). Read more...